News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
265,518 Results
Type
Article (14148)
Company Profile (282)
Press Release (251088)
Section
Business (79474)
Career Advice (153)
Deals (13222)
Drug Delivery (35)
Drug Development (50421)
Employer Resources (31)
FDA (5710)
Job Trends (5127)
News (144335)
Policy (10027)
Tag
2024 BioCapital Digital (6)
2024 BioForest Digital (1)
2024 BioMidwest Digital (4)
2024 Bio NC Digital (4)
2024 Bio NC Standard (1)
2024 Biotech Bay Standard (11)
2024 Biotech Beach Digital (5)
2024 Biotech Beach Standard (3)
2024 Genetown Digital (7)
2024 Genetown Standard (7)
2024 Lone Star Bio Digital (4)
2024 Pharm Country Digital (4)
2024 Pharm Country Standard (4)
2025 BioForest Digital (3)
2025 Lone Star Bio Digital (3)
2026 BioMidwest Elite (1)
2026 Biotech Bay Elite (1)
2026 Biotech Bay Standard (1)
2026 Biotech Beach Elite (1)
2026 Genetown Elite (2)
2026 Pharm Country Elite (1)
Academia (908)
Accelerated approval (2)
Adcomms (12)
Allergies (49)
Alliances (21620)
ALS (54)
Alzheimer's disease (809)
Antibody-drug conjugate (ADC) (79)
Approvals (5716)
Artificial intelligence (101)
Autoimmune disease (7)
Automation (5)
Bankruptcy (103)
Best Places to Work (4560)
BIOSECURE Act (5)
Biosimilars (36)
Biotechnology (232)
Bladder cancer (40)
Brain cancer (19)
Breast cancer (135)
Cancer (1184)
Cardiovascular disease (95)
Career advice (132)
Career pathing (2)
CAR-T (102)
Cell therapy (294)
Cervical cancer (5)
Clinical research (40717)
Collaboration (470)
Compensation (204)
Complete response letters (13)
COVID-19 (1029)
CRISPR (34)
C-suite (130)
Cystic fibrosis (75)
Data (1235)
Denatured (11)
Depression (27)
Diabetes (113)
Diagnostics (1285)
Digital health (3)
Diversity (2)
Diversity, equity & inclusion (9)
Drug discovery (74)
Drug pricing (27)
Drug shortages (3)
Duchenne muscular dystrophy (65)
Earnings (29418)
Editorial (16)
Employer branding (4)
Employer resources (29)
Events (47912)
Executive appointments (380)
FDA (6271)
Featured Employer (32)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (4)
Frontotemporal dementia (6)
Funding (434)
Gene editing (82)
Generative AI (9)
Gene therapy (218)
GLP-1 (344)
Government (1074)
Grass and pollen (2)
Guidances (18)
Healthcare (6585)
Huntington's disease (21)
IgA nephropathy (18)
Immunology and inflammation (72)
Indications (16)
Infectious disease (1084)
Inflammatory bowel disease (109)
Inflation Reduction Act (8)
Influenza (16)
Intellectual property (52)
Interviews (17)
IPO (7257)
IRA (11)
Job creations (860)
Job search strategy (127)
Kidney cancer (6)
Labor market (4)
Layoffs (198)
Leadership (2)
Legal (1385)
Liver cancer (30)
Lung cancer (169)
Lymphoma (78)
Machine learning (1)
Management (7)
Manufacturing (110)
MASH (46)
Medical device (2585)
Medtech (2586)
Mergers & acquisitions (6226)
Metabolic disorders (340)
Multiple sclerosis (47)
NASH (13)
Neurodegenerative disease (53)
Neuropsychiatric disorders (22)
Neuroscience (1152)
NextGen: Class of 2025 (2014)
Non-profit (852)
Northern California (1432)
Now hiring (21)
Obesity (177)
Opinion (99)
Ovarian cancer (50)
Pain (39)
Pancreatic cancer (49)
Parkinson's disease (97)
Partnered (6)
Patents (100)
Patient recruitment (58)
Peanut (35)
People (25425)
Pharmaceutical (48)
Pharmacy benefit managers (5)
Phase I (14370)
Phase II (18942)
Phase III (11975)
Pipeline (587)
Podcasts (42)
Policy (33)
Postmarket research (852)
Preclinical (6016)
Press Release (30)
Prostate cancer (50)
Psychedelics (35)
Radiopharmaceuticals (210)
Rare diseases (265)
Real estate (1414)
Recruiting (12)
Regulatory (8508)
Reports (14)
Research institute (936)
Resumes & cover letters (17)
Rett syndrome (3)
RNA editing (2)
RSV (10)
Schizophrenia (53)
Series A (85)
Series B (52)
Service/supplier (1)
Sickle cell disease (37)
Southern California (1274)
Special edition (11)
Sponsored (11)
Startups (1970)
State (1)
Stomach cancer (4)
Supply chain (18)
The Weekly (31)
United States (11340)
Vaccines (198)
Venture capitalists (27)
Webinars (7)
Weight loss (99)
Women's health (14)
Worklife (2)
Date
Today (68)
Last 7 days (345)
Last 30 days (1722)
Last 365 days (20243)
2025 (3690)
2024 (20553)
2023 (22414)
2022 (26823)
2021 (27805)
2020 (23356)
2019 (16224)
2018 (11738)
2017 (13746)
2016 (11839)
2015 (14350)
2014 (10392)
2013 (7484)
2012 (7532)
2011 (7615)
2010 (7428)
Location
Africa (148)
Alabama (37)
Alaska (2)
Arizona (50)
Arkansas (5)
Asia (17150)
Australia (2904)
California (3272)
Canada (1008)
China (290)
Colorado (127)
Connecticut (139)
Delaware (82)
Europe (36889)
Florida (382)
Georgia (96)
Idaho (16)
Illinois (200)
India (7)
Indiana (81)
Iowa (1)
Japan (64)
Kansas (58)
Kentucky (5)
Louisiana (3)
Maine (11)
Maryland (427)
Massachusetts (2597)
Michigan (68)
Minnesota (129)
Mississippi (1)
Missouri (22)
Montana (14)
Nebraska (4)
Nevada (14)
New Hampshire (13)
New Jersey (825)
New Mexico (11)
New York (901)
North Carolina (500)
North Dakota (4)
Northern California (1432)
Ohio (102)
Oklahoma (8)
Oregon (21)
Pennsylvania (621)
Puerto Rico (1)
Rhode Island (13)
South America (207)
South Carolina (3)
Southern California (1274)
Tennessee (24)
Texas (367)
Utah (47)
Virginia (65)
Washington D.C. (27)
Washington State (307)
Wisconsin (13)
265,518 Results for "dermata therapeutics".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Dermata to Present on BioPub on January 31, 2025
January 30, 2025
·
4 min read
Press Releases
Dermata Receives Notice of Acceptance of Australian Patent Application for Topical Botulinum Toxin Treatment for Hyperhidrosis
February 26, 2025
·
5 min read
Press Releases
Dermata Therapeutics Announces $2.55 Million Private Placement Priced At-The-Market Under Nasdaq Rules
January 23, 2025
·
5 min read
Press Releases
Dermata Therapeutics Announces Closing of $2.55 Million Private Placement Priced At-The-Market Under Nasdaq Rules
January 23, 2025
·
5 min read
Press Releases
Dermata Announces that Last Patient Completes Last Visit in Pivotal XYNGARI™ Phase 3 STAR-1 Clinical Trial for Acne
March 4, 2025
·
7 min read
Business
Dermata Therapeutics Provides Corporate Update and Reports First Quarter 2024 Financial Results
Dermata Therapeutics, Inc. (Nasdaq:DRMA)(Nasdaq;DRMAW) (“Dermata,” or the “Company”), a late-stage biotechnology company focused on the treatment of medical and aesthetic skin diseases and conditions, today highlighted recent corporate progress and reported financial results for the first quarter ended March 31, 2024.
May 15, 2024
·
7 min read
Press Releases
Dermata Expands Patent Portfolio with Issuance of New U.S. Patent for Next-Generation Acne Treatment
January 28, 2025
·
5 min read
Press Releases
Dermata Therapeutics Provides Corporate Update and Reports Third Quarter 2024 Financial Results
November 14, 2024
·
7 min read
Press Releases
Dermata and Revance Enter Clinical Trial Collaboration Agreement for the Topical Application of Xyngari(TM) with Daxxify(R)
January 21, 2025
·
13 min read
Press Releases
Dermata Receives Approval from FDA for the Proprietary Name Xyngari(TM)
December 17, 2024
·
6 min read
1 of 26,552
Next
